Vitroscope raises $7M seed
Announced 3 November 2026
◆ The Round
Vitroscope raised $7M in seed funding, announced on 3 November 2026, led by Cerberus Ventures, YZR Capital, with participation from Arcas Ventures, Golden Egg Check, Devico Invest, Carles Reina, Fàtima Godall, Oskari Pétas, the Research Council of Norway. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Vitroscope
Biotech company developing automated perfusion platforms that maintain living tissue under controlled flow conditions for drug discovery and translational research. Vitroscope is based in Norway and currently at seed stage, operating in Biotech.
◆ Investors
LeadCerberus Ventures, YZR Capital
ParticipationArcas Ventures, Golden Egg Check, Devico Invest, Carles Reina, Fàtima Godall, Oskari Pétas, the Research Council of Norway
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Vitroscope's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Vitroscope raise?
Vitroscope raised $7M in its seed round, announced 2026-11-03.
Who invested in Vitroscope's seed round?
The round was led by Cerberus Ventures and YZR Capital, with participation from Arcas Ventures, Golden Egg Check, Devico Invest, Carles Reina, Fàtima Godall, Oskari Pétas and the Research Council of Norway.
What does Vitroscope do?
Biotech company developing automated perfusion platforms that maintain living tissue under controlled flow conditions for drug discovery and translational research.
Verified 3 November 2026 · Sources: public filings